VP-16-213用于晚期乳腺癌患者的II期评估：西南肿瘤协作组研究 - Suppr

Suppr

超能文献

Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.

作者信息

Vaughn C B, Panettiere F, Thigpen T, Bottomley R, Hoogstraten B, Samal B

出版信息

Cancer Treat Rep. 1981 May-Jun;65(5-6):443-5.

PMID:7237465

Abstract

摘要

相似文献

Phase II evaluation of VP-16-213 in patients with advanced breast cancer: a Southwest Oncology Group Study.VP-16-213用于晚期乳腺癌患者的II期评估：西南肿瘤协作组研究

Cancer Treat Rep. 1981 May-Jun;65(5-6):443-5.

VP-16 and adriamycin in patients with advanced breast cancer.

Am J Clin Oncol. 1982 Oct;5(5):505-9.

Doxorubicin plus VP-16-213 for the treatment of refractory breast carcinoma.

Am J Clin Oncol. 1982 Oct;5(5):515-9.

[A phase I study of VP-16-213 (VP, etoposide) by single and 5-day intravenous administration].[依托泊苷（VP-16-213，VP）单次及连续5天静脉给药的I期研究]

Gan To Kagaku Ryoho. 1986 Feb;13(2):319-29.

[A phase II study of NK171 (etoposide)].

Gan To Kagaku Ryoho. 1985 Oct;12(10):2011-7.

[Phase II study of etoposide (VP-16) in the form of oral capsules for malignant lymphomas].

Gan To Kagaku Ryoho. 1985 Jul;12(7):1482-6.

Phase I study of VP-16-213 (Etoposide) administered as a continuous 5-day infusion.依托泊苷（VP - 16 - 213）持续5天静脉输注的I期研究。

Cancer Treat Rep. 1981 Sep-Oct;65(9-10):887-9.

[Collaborative phase II study of etoposide (NK-171). Urological Cooperative Study Group of etoposide (NK-171)].

Gan No Rinsho. 1985 Jul;31(8):944-52.

Phase II clinical trial of weekly administration of VP-16-213 in small cell bronchogenic carcinoma.

Cancer Treat Rep. 1977 May-Jun;61(3):489-90.

[Phase I study of an oral administration of VP 16-213].

Gan To Kagaku Ryoho. 1983 Nov;10(11):2403-7.

引用本文的文献

Chronic oral etoposide in advanced breast cancer.晚期乳腺癌的慢性口服依托泊苷治疗

Cancer Chemother Pharmacol. 1994;33(6):527-9. doi: 10.1007/BF00686513.

Vincristine with high-dose etoposide in advanced breast cancer: a phase II trial of the Piedmont Oncology Association.

Cancer Chemother Pharmacol. 1994;35(2):165-8. doi: 10.1007/BF00686641.

Second-line chemotherapy with long-term low-dose oral etoposide in patients with advanced breast cancer.

Breast Cancer Res Treat. 1995 May;34(2):185-9. doi: 10.1007/BF00665790.

The podophyllotoxin derivatives VP16-213 and VM26.

Cancer Chemother Pharmacol. 1982;7(2-3):73-80. doi: 10.1007/BF00254525.

Chemotherapy of breast cancer.乳腺癌的化疗

Med Oncol Tumor Pharmacother. 1984;1(3):169-92. doi: 10.1007/BF02934139.

Phase II study with etoposide in previously untreated advanced breast cancer.

Cancer Chemother Pharmacol. 1989;24(4):261-3. doi: 10.1007/BF00257630.

Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.依托泊苷。对其药效学和药代动力学特性以及在癌症联合化疗中的治疗潜力的综述。

Drugs. 1990 Mar;39(3):438-90. doi: 10.2165/00003495-199039030-00008.

Ifosfamide/etoposide and mesna uroprotection in advanced breast cancer.

Cancer Chemother Pharmacol. 1990;26 Suppl:S87-90. doi: 10.1007/BF00685431.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验